The critical role of CD133 + CD44 +/high tumor cells in hematogenous metastasis of liver cancers

Cell Research

Volumn 22, Issue 1, 2012, Pages 259-272

  Hou, Ying ^a,b   Zou, Qifei ^c   Ge, Ruiliang ^c   Shen, Feng ^c   Wang, Yizheng ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; Tumor initiating cells

Indexed keywords

CD133 ANTIGEN; CD44 PROTEIN, HUMAN; GLYCOPROTEIN; HERMES ANTIGEN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER INVASION; CELL COUNT; CELL STRAIN HEPG2; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; PORTAL VEIN; VASCULAR TUMOR;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CELL COUNT; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, VASCULAR TISSUE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PORTAL VEIN; TUMOR MARKERS, BIOLOGICAL;

MUS MUSCULUS;

EID: 84860412513     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2011.139     Document Type: Article

References (39)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the world-wide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29. (Pubitemid 29409471)
2. Jin F, Xiang YB, Gao YT. Cancer survival in Shanghai, People's Republic of China. IARC Sci Publ 1998; 145:37-50.
3. Liang XH, Loncarevic IF, Tang ZY, Yu YQ, Zentgraf H, Schroder CH. Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumours. J Gastroenterol Hepatol 1991; 6:77-80.
4. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127:603-608.
5. Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359:1995-2004.
6. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563-572. (Pubitemid 37328923)
7. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007; 58:267-284. (Pubitemid 46706514)
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-3988. (Pubitemid 36418143)
9. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313-323. (Pubitemid 47355323)
10. Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8:R59.
11. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmem-brane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90:5013-5021. (Pubitemid 28007218)
12. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132:2542-2556. (Pubitemid 46890873)
13. Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007; 120:1444-1450. (Pubitemid 46355378)
14. Song W, Li H, Tao K, et al. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract 2008; 62:1212-1218. (Pubitemid 351977611)
15. Salnikov AV, Kusumawidjaja G, Rausch V, et al. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter. Cancer Lett 2009; 275:185-193.
16. Washington K, Telen MJ Gottfried MR. Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. Liver 1997; 17:17-23. (Pubitemid 27092777)
17. Mathew J, Hines JE, Obafunwa JO, Burr AW, Toole K, Burt AD. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol 1996; 179:74-79. (Pubitemid 26182868)
18. Zheng Q, Tang ZY, Xue Q, et al. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol 2000; 126:641-646.
19. Schimanski CC, Bahre R, Gockel I, et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 2006; 95:210-217. (Pubitemid 44050921)
20. Woo M, Park K, Nam J, Kim JC. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 2007; 22:1064-1070. (Pubitemid 47019841)
21. Erreni M, Bianchi P, Laghi L, et al. Expression of chemokines and chemokine receptors in human colon cancer. Methods Enzymol 2009; 460:105-121.
22. Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136:1012-1024.
23. Ma S, Chan KW, Lee TK, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6:1146-1153.
24. Yasui M, Harada A, Nonami T, Takeuchi Y, Nakao A, Takagi H. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis. World J Surg 1997; 21:860-864.
25. Zhu Z, Hao X, Yan M, et al. Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma. Int J Cancer 2010; 126:2067-2078.
26. Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M. Expression of CD44 in human hepatocellular carcinoma cell lines. Hepatology 1995; 21:1276-1284.
27. Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13:153-166. (Pubitemid 351163165)
28. Herrera MB, Bruno S, Buttiglieri S, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24:2840-2850. (Pubitemid 46053020)
29. Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 2006; 24:1852-1858. (Pubitemid 44474161)
30. Jones EA, Kinsey SE, English A, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46:3349-3360. (Pubitemid 35453547)
31. Lee TK, Poo R TP, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006, 12:5369-5376. (Pubitemid 44497250)
32. Yang MH, Chen CL, Chau GY, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50:1464-1473.
33. Patrawala L, Calhoun T, Li H, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
34. Henry JC, Park JK, Jiang J, et al. mir-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2010; 403:120-125.
35. Morton CL and Houghton PJ. Establishment of human tumor xenografts in immunodeficient mice Nat Protoc 2007; 2:247-250. (Pubitemid 47040037)
36. Shi Y, Ding X, He ZH, et al. Critical role of TRPC6 channels in G2 phase transition and the development of human esophageal cancer. Gut 2009; 58:1443-1450.
37. Bazarbachi A, Abou Merhi R, Gessain A, et al. Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res 2004; 64:2039-2046. (Pubitemid 38339451)
38. Bender FL, Fischer M, Funk N, et al. High-efficiency gene transfer into cultured embryonic motoneurons using recombinant lentiviruses. Histochem Cell Biol 2007; 127:439-448. (Pubitemid 46385566)
39. Tang ZY, Ye SL, Liu YK, et al. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130:187-196.